⚠️Annoyed—the US CDC still does **not seem to classify the #DeltaVariant as a “Variant of Concern”**!! #B16172 is still merely “variant of interest” on @CDCgov website, updated just this weekend. Both @WHO & 🇬🇧 upgraded Delta to VOC weeks ago. CDC act now! cdc.gov/coronavirus/20…
2) Because this is what new cases of #DeltaVariant#COVID19 is doing in the UK 🇬🇧… US 🇺🇸 is a trouble if don’t act now
5) The #DeltaVariant is truly a scourge. We saw what it did to India 🇮🇳, and now we are seeing another wave in 🇬🇧 and hospitalizations increasing there, and #DeltaVariant rising in the US 🇺🇸 as well…. See thread 🧵 video explainers: ⬇️
7) As Dr Fauci warned recently: “The problem you get into … is that a single dose only provides about ~30% effectiveness [against #DeltaVariant]—so that is really an issue you gotta be careful”, as Fauci tells @nehakhanna_07 recently.
8) Even @WHO_Europe chief is warning that the #DeltaVariant is soon to take hold across Europe and 1 dose isn’t enough. US CDC needs to raise the alarm and upgrade #DeltaVariant to VOC ASAP…
9) Canadian hospitals area also seeing problems with the #DeltaVariant. 5 out of 6 infected hospital workers were even 2-dose vaccinated. Let that sink in. Delta is that problematic.
DIFFERENT SYMPTOMS—‘Loss of smell’ is no longer a top 10 symptom of the new #DeltaVariant. A headache, sore throat & runny nose are now the most common. New study says catching Delta #COVID19 can feel different— "more like a bad cold" for younger people.🧵 bbc.com/news/health-57…
2) Since the start of May, we have been looking at the top symptoms in the app users - and they are not the same as they were," he says.
The change appears linked to the rise in the Delta variant, first identified in India and now accounting for 90% of Covid cases in the UK.
3) Fever remains quite common but loss of smell no longer appears in the top 10 symptoms, Prof Spector says.
"This variant seems to be working slightly differently," he says.
📍1 in 4–almost a quarter of people infected develop at least one lingering health problem after 30 days with #COVID19. The most common included pain, breathing trouble, high cholesterol, malaise and/or fatigue and high blood pressure. 🧵 google.com/amp/s/time.com…
2) But the reported post-COVID symptoms were quite varied, running the gamut from depression and anxiety to skin conditions to heart issues and gastrointestinal distress.
3) most Long COVID symptoms are more commonly reported by women than men.
Health analyzed private health care claim records for nearly 2 million people diagnosed with COVID-19 in 2020. The people in the study ranged in age from babies to the elderly;
BREAKING—CDC now officially declares #DeltaVariant a “variant of concern”—because much more transmissible (50% faster than #B117, 2x than original strain), more severe (2.5x hospitalization risk than B117, 4x original) & 1 dose vaccine evasive.🧵 #COVID19 cdc.gov/coronavirus/20…
2) This comes on the heels of the urgent advocacy by many to demand CDC upgrade to VOC. Even WHO and UK 🇬🇧 raised #DeltaVariant to VOC weeks ago. CDC is very late on this.
3) We have known #DeltaVariant has been rising fast in the Us for quite a while. Over a week ago, we already knew it was exponentially rising across the US. It’s doubling every 2 weeks overall, but doubling every week in certain states.
⚠️New CDC warning on rising RSV again. Coincided with dropping of mask mandates & usage. ➡️ “The CDC is issuing this health advisory to notify clinicians and caregivers about increased interseasonal respiratory syncytial virus (RSV) activity across parts of the Southern US.” 🧵
2) CDC: “Due to this increased activity, CDC encourages broader testing for RSV among patients presenting with acute respiratory illness who test negative for SARS-CoV-2, the virus that causes COVID-19. RSV can be associated with severe disease in young children and older adults”
3) “RSV is the most common cause of bronchiolitis and pneumonia in children under one year of age in the United States. Infants, young children, and older adults with chronic medical conditions are at risk of severe disease from RSV infection.
So, vaccines good against hospitalizations, yes, but not when just 1 dose against #DeltaVariant, not when <50% fully vaxxed. Despite new controversial case-control efficacy study (very small & assumption laden)—🇬🇧hospital #COVID19 surges just don’t lie.🧵 assets.publishing.service.gov.uk/government/upl…
2) Note how much weaker 1 dose is versus 2 doses for the #DeltaVariant for both infection and hospitalization.
3) What is the first clue the new controversial study is unreliable? The Pfizer 2 dose results aren’t even significant due to wide 95% CIs. Second, the 1 dose is stronger than 2 dose for Pfizer? Hog wash. We know that’s not true and opposite. This is why this study unreliable.
Masks are coming off—the cold and flu is now back. Coincidence? No. The CDC just issued a health advisory about increased cases of respiratory syncytial virus, or RSV, across parts of the southern US — something CDC hadn’t seen since April 2020. #MaskOn bostonglobe.com/2021/06/14/met…
2) RSV is a cold-like respiratory illness that produces symptoms similar to COVID, and can cause severe illness in older adults and young children. It disappeared for a year because of #COVID19 mitigations. It’s now back because masks are coming off, especially in the South.
3) Since the state’s mask mandate was lifted at the end of May, face coverings have started to come off — and stay off. But according to infectious diseases doctors, the return of facial freedom might come with some downsides, like a resurgence in cases of the common cold and flu